{
     "PMID": "25690661",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160229",
     "LR": "20171116",
     "IS": "1875-8908 (Electronic) 1387-2877 (Linking)",
     "VI": "45",
     "IP": "1",
     "DP": "2015",
     "TI": "Increased susceptibility of dyslipidemic LSR+/- mice to amyloid stress is associated with changes in cortical cholesterol levels.",
     "PG": "195-204",
     "LID": "10.3233/JAD-142127 [doi]",
     "AB": "Alzheimer's disease (AD) is a neurodegenerative disease that has been linked to changes in cholesterol metabolism. Neuronal cholesterol content significantly influences the pro-apoptotic effect of amyloid-beta peptide42 (Abeta42), which plays a key role in AD development. We previously reported that aged mice with reduced expression of the lipolysis stimulated lipoprotein receptor (LSR+/-), demonstrate membrane cholesterol accumulation and decreased intracellular lipid droplets in several brain regions, suggesting a potential role of LSR in brain cholesterol distribution. We questioned if these changes rendered the LSR+/- mouse more susceptible to Abeta42-induced cognitive and biochemical changes. Results revealed that intracerebroventricular injection of oligomeric Abeta42 in male 15-month old LSR+/+ and LSR+/- mice led to impairment in learning and long-term memory and decreased cortical cholesterol content of both groups; these effects were significantly amplified in the Abeta42-injected LSR+/- group. Total latency of the Morris test was significantly and negatively correlated with cortical cholesterol content of the LSR+/- mice, but not of controls. Significantly lower cortical PSD95 and SNAP-25 levels were detected in Abeta42-injected LSR+/- mice as compared to Abeta42-injected LSR+/+ mice. In addition, 24S-hydroxy cholesterol metabolite levels were significantly higher in the cortex of LSR+/- mice. Taken together, these results suggest that changes in cortex cholesterol regulation as a result of the LSR+/- genotype were linked to increased susceptibility to amyloid stress, and we would therefore propose the aged LSR+/- mouse as a new model for understanding the link between modified cholesterol regulation as a risk factor for AD.",
     "FAU": [
          "Pincon, Anthony",
          "Thomas, Melanie H",
          "Huguet, Marion",
          "Allouche, Ahmad",
          "Colin, Julie C",
          "Georges, Alain",
          "Derrien, Annabelle",
          "Lanhers, Marie-Claire",
          "Malaplate-Armand, Catherine",
          "Oster, Thierry",
          "Corbier, Catherine",
          "Pillot, Thierry",
          "Olivier, Jean Luc",
          "Yen, Frances T"
     ],
     "AU": [
          "Pincon A",
          "Thomas MH",
          "Huguet M",
          "Allouche A",
          "Colin JC",
          "Georges A",
          "Derrien A",
          "Lanhers MC",
          "Malaplate-Armand C",
          "Oster T",
          "Corbier C",
          "Pillot T",
          "Olivier JL",
          "Yen FT"
     ],
     "AD": "Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France INSERM, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. Universite de Lorraine, LARSA, IUT-NB, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France Biochemistry Department, CHU de Nancy, Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France. INSERM, Vandoeuvre-les-Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France Biochemistry Department, CHU de Nancy, Nancy, France. Universite de Lorraine, UR AFPA, EA3998, Vandoeuvre-les-Nancy, Frace INRA, UR AFPA, USC 0340 INRA, Vandoeuvre-les-Nancy, France INSERM, Vandoeuvre-les-Nancy, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "J Alzheimers Dis",
     "JT": "Journal of Alzheimer's disease : JAD",
     "JID": "9814863",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Disks Large Homolog 4 Protein)",
          "0 (Dlg4 protein, mouse)",
          "0 (Hydroxycholesterols)",
          "0 (Membrane Proteins)",
          "0 (Peptide Fragments)",
          "0 (RNA, Messenger)",
          "0 (Receptors, Lipoprotein)",
          "0 (Snap25 protein, mouse)",
          "0 (Synaptosomal-Associated Protein 25)",
          "0 (amyloid beta-protein (1-42))",
          "0 (angulin-1 protein, mouse)",
          "47IMW63S3F (24-hydroxycholesterol)",
          "97C5T2UQ7J (Cholesterol)",
          "EC 2.7.4.8 (Guanylate Kinases)"
     ],
     "SB": "IM",
     "MH": [
          "Amyloid beta-Peptides/*pharmacology",
          "Analysis of Variance",
          "Animals",
          "Cerebral Cortex/*drug effects/*metabolism",
          "Cholesterol/*metabolism",
          "Disks Large Homolog 4 Protein",
          "Gene Expression Regulation/drug effects/genetics",
          "Guanylate Kinases/metabolism",
          "Hippocampus/drug effects/metabolism",
          "Hydroxycholesterols/metabolism",
          "Maze Learning/drug effects/physiology",
          "Membrane Proteins/metabolism",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Transgenic",
          "Peptide Fragments/*pharmacology",
          "RNA, Messenger",
          "Receptors, Lipoprotein/*deficiency/genetics",
          "Regression Analysis",
          "Synaptosomal-Associated Protein 25/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "amyloid-beta oligomers",
          "animal model",
          "cholesterol",
          "cognitive impairment",
          "learning",
          "lipolysis stimulated lipoprotein receptor",
          "memory"
     ],
     "EDAT": "2015/02/19 06:00",
     "MHDA": "2016/03/02 06:00",
     "CRDT": [
          "2015/02/19 06:00"
     ],
     "PHST": [
          "2015/02/19 06:00 [entrez]",
          "2015/02/19 06:00 [pubmed]",
          "2016/03/02 06:00 [medline]"
     ],
     "AID": [
          "576P0053QX072MQ9 [pii]",
          "10.3233/JAD-142127 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Alzheimers Dis. 2015;45(1):195-204. doi: 10.3233/JAD-142127.",
     "term": "hippocampus"
}